Pharmacokinetics and renal tolerance of aztreonam in premature infants.


Aztreonam (30 mg/kg of body weight) was administered intravenously over 3 min every 12 h to 30 preterm neonates divided into two groups according to gestational age (mean age for group A was less than 30 weeks and mean age for group B was greater than 30 weeks) and birth weight (mean weight for group A was less than 1,500 g and mean weight for group B was greater than 1,500 g). Blood and urine samples were analyzed by microbiological assay. The pharmacokinetics were described by one-compartment and noncompartment models. The mean half-life and clearance for premature infants weighing less than 1,500 g were 5.33 +/- 3.61 h and 1.52 +/- 1.33 ml/min/kg, respectively; for those weighing more than 1,500 g, the values were 4.08 +/- 2.28 h and 2.41 +/- 2.10 ml/min/kg, respectively. The mean urinary concentration of aztreonam in 15 premature infants during the first 6 h of therapy was 242.72 +/- 188.19 micrograms/ml, with a mean percentage of elimination of 13.29%. Urinary excretion of N-acetyl-beta-D-glucosaminidase (a specific and sensitive test for the detection of drug-induced renal tubule damage) did not show significant differences in our group of premature infants compared with that in a control group. The dose of 30 mg/kg and a dosage interval of 8 to 12 h could be recommended for the treatment of suitable bacterial infections in all premature infants.

3 Figures and Tables


Citations per Year

530 Citations

Semantic Scholar estimates that this publication has 530 citations based on the available data.

See our FAQ for additional information.

Cite this paper

@article{Cuzzolin1991PharmacokineticsAR, title={Pharmacokinetics and renal tolerance of aztreonam in premature infants.}, author={Laura Cuzzolin and Vassilios Fanos and D. Zambreri and Ezio Maria Padovani and Giuseppina Benoni}, journal={Antimicrobial agents and chemotherapy}, year={1991}, volume={35 9}, pages={1726-8} }